entity

H2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about H2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

15Connections
13Hypotheses
4Analyses
13Outgoing
2Incoming
1Experiments
4Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

JPH2 — Junctophilin 2

gene · 3521 words

PTCH2 Gene

gene · 3361 words

USH2A Protein

protein · 2866 words

HNRNPH2 Gene

gene · 2633 words

N-Cadherin (CDH2) Protein

protein · 2513 words

Outgoing (13)

TargetRelationTypeStr
CHOP_DDIT3suppressed_by_high_dose_melatoningene_protein0.00
caspase_12murine_specific_targetgene_protein0.00
AQP4enhances_functionprotein0.00
glymphatic_systemenhances_clearancesystem0.00
CD14associated_withgene0.50

Incoming (2)

SourceRelationTypeStr
ADCS_trialfailed_to_replicate_preclinicalstudy0.00
H1associated_withhypothesis0.50

Targeting Hypotheses (13)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
H2: Impaired Autophagy Receptor Recruitment Traps G3BP1 Gran 0.737 neurodegeneration How do pathological stress granules tran
EZH2-Mediated H3K27me3 Spreading in Senescent ALS Microglia 0.714 ALS What are the mechanisms by which microgl
H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective 0.699 neurodegeneration How does engineered C. butyricum cross t
Pharmacological EZH2 Inhibition Resets Polycomb-Mediated Rep 0.680 neurodegeneration epigenetic reprogramming aging neurons
FABP5/7 Inhibition (H2): Lipid Relay Interruption 0.670 neurodegeneration Does restoring neuronal AMPK activity re
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem 0.646 neurodegeneration Selective vulnerability of entorhinal co
H2: Perforant Path Synapse Loss via Early Complement Cascade 0.610 neurodegeneration Entorhinal cortex layer II vulnerability
H2: H3K9me3 Heterochromatin Collapse Enables Cryptic Transcr 0.610 neurodegeneration Investigate mechanisms of epigenetic rep
Persistent γH2AX+53BP1 Foci with DREAM Complex Activation De 0.560 neurodegeneration How can senescent microglia be molecular
Dual-Mechanism Model: G2019S Increases Both Baseline AND Sig 0.550 neurodegeneration Do pathogenic LRRK2 mutations amplify vo
H2: SASP Neutralization via JAK/STAT Inhibition Preserves As 0.550 neurodegeneration Do APOE4-driven senescent astrocytes cau
EZH2 Inhibitor Therapy to Restore Neuronal Identity Genes 0.390 neurodegeneration Comparative epigenetic signatures across
H2S/butyrate imbalance drives enteric alpha-synuclein pathol 0.380 Parkinson's disease -

Mentioning Analyses (4)

Scientific analyses that reference this entity

What is the minimum effective dose of trazodone required for disease-modifying e

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.605

What is the optimal dosage and timing of melatonin administration for AD prevent

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.735

What mechanisms explain how IDH1/IDH2 mutations with reduced enzymatic activity

neurodegeneration | 2026-04-13 | 0 hypotheses

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 5 hypotheses Top: 0.720

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Clinical outcome analysis based on IDH mutation status clinical gliomas 0.850 0.00 human patients proposed N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresista [PMID:36637036] Shigeta K, Hasegawa M, Hishiki T, Naito EMBO J 2023 1
Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydr [PMID:31131326] Tommasini-Ghelfi S, Murnan K, Kouri FM, Sci Adv 2019 1
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcino [PMID:28622513] Cancer Genome Atlas Research Network. El Cell 2017 1
Diagnostic, prognostic and predictive relevance of molecular markers in gliomas. [PMID:25944653] Brandner S, von Deimling A Neuropathol Appl Neurobiol 2015 1
IDH1 and IDH2 mutations in gliomas. [PMID:19228619] Yan H, Parsons DW, Jin G, McLendon R, Ra N Engl J Med 2009 1
Advancements in targeted therapies for acute myeloid leukemia. [PMID:41576755] Connor MP, Barsouk A, Elghawy O, Lai C Curr Opin Pharmacol 2026 0
ZNF395 Is a Hypoxia-Responsive Regulator of Mitochondrial Glutaminolysis in Clea [PMID:41637546] Koh J, Liao C, Ng MSW, Hong JH, Heng HL Cancer Res 2026 0
Serine mediates protection against calcium oxalate nephrolithiasis by attenuatin [PMID:41930872] Yan X, Li G, Wang Z, Li C, Shi Y et al. Int Immunopharmacol 2026 0
Protective or Pathogenic? Kinase activity and the neurodevelopmental origins of [PMID:41344986] Gatto EM, Espay AJ, Espindola M, Da Prat Parkinsonism & related disorde 2026 0
Chemical Proteomics Reveals Human Off-Targets of Fluoroquinolone Induced Mitocho [PMID:39964703] ["Reinhardt T", "El Harraoui Y", "Rothem Angewandte Chemie (Internation 2025 0
Succinate-loaded tumor cell-derived microparticles reprogram tumor-associated ma [PMID:40203081] Lu S, Li J, Li Y, Liu S, Liu Y, Liang Y, Science translational medicine 2025 0
Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restrainin [PMID:38171332] Si X, Shao M, Teng X, Huang Y, Meng Y, W Cell metabolism 2024 0
Metabolic dysregulation and emerging therapeutical targets for hepatocellular ca [PMID:35256934] Du D, Liu C, Qin M, Zhang X, Xi T, Yuan Acta pharmaceutica Sinica. B 2022 0
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to [PMID:35012605] Xu E, Boddu R, Abdelmotilib HA, Sokratia Molecular neurodegeneration 2022 0
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in [PMID:34125248] Fan, Nirujogi, Garrido, Ruiz-Martín Acta neuropathologica 2022 0
Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab [PMID:29127255] ["Fan Ying", "Howden Andrew J M", "Sarha The Biochemical journal 2018 0
Opportunities and obstacles for deep learning in biology and medicine. [PMID:29618526] ["Ching T", "Himmelstein D", "Beaulieu-J Journal of the Royal Society, 2018 0
Autophagy mediates degradation of nuclear lamina. [PMID:26524528] ["Dou Z", "Xu C", "Donahue G", "Shimi T" Nature 2015 0
Loop-based multiple heart-cutting two-dimensional liquid chromatography for targ [PMID:25897943] ["Pursch M", "Buckenmaier S"] Analytical chemistry 2015 0
Methanesulfonic acid sodium salt protects retina from acute light damage in mice [PMID:22882854] Wang HY, Gu Q, Xu X Chinese medical journal 2012 0

Debates (4)

Multi-agent debates referencing this entity

What is the minimum effective dose of trazodone required for disease-modifying e

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

What is the optimal dosage and timing of melatonin administration for AD prevent

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

This analysis aims to elucidate the mechanisms by which gut microbiome dysbiosis

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

The abstract shows that IDH mutations reduce protein enzymatic activity yet para

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

Related Research

Hypotheses and analyses mentioning H2 in their description or question text

Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancement

Score: 0.646 · neurodegeneration · 2026-04-02

## Mechanistic Overview Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancement starts from the claim that modul

H2: Perforant Path Synapse Loss via Early Complement Cascade Activation

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview H2: Perforant Path Synapse Loss via Early Complement Cascade Activation starts from the claim th

H2: H3K9me3 Heterochromatin Collapse Enables Cryptic Transcription of Repetitive

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview H2: H3K9me3 Heterochromatin Collapse Enables Cryptic Transcription of Repetitive Elements starts

Persistent γH2AX+53BP1 Foci with DREAM Complex Activation Defines Irreversibly A

Score: 0.560 · neurodegeneration · 2026-04-22

## Mechanistic Overview Persistent γH2AX+53BP1 Foci with DREAM Complex Activation Defines Irreversibly Arrested Microgli

Dual-Mechanism Model: G2019S Increases Both Baseline AND Signal-Dependent Phosph

Score: 0.550 · neurodegeneration · 2026-04-26

G2019S has two separable effects: (1) increases catalytic efficiency at baseline (higher floor), AND (2) increases LRRK2

H2: SASP Neutralization via JAK/STAT Inhibition Preserves Astrocyte Function

Score: 0.550 · neurodegeneration · 2026-04-22

## Mechanistic Overview H2: SASP Neutralization via JAK/STAT Inhibition Preserves Astrocyte Function starts from the cla

EZH2 Inhibitor Therapy to Restore Neuronal Identity Genes

Score: 0.390 · neurodegeneration · 2026-04-25

## Mechanistic Overview The histone methyltransferase EZH2 (Enhancer of Zeste Homolog 2) is the catalytic subunit of th